-
公开(公告)号:ES2423668T3
公开(公告)日:2013-09-23
申请号:ES10720502
申请日:2010-05-20
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG , ABBVIE INC
Inventor: WELCH DENNIE S , AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D491/04 , C07D495/04
Abstract: Un compuesto de fórmula (I):**Fórmula** o una sal farmacéuticamente aceptable del mismo,donde A está seleccionado entre el grupo que consiste en R1, R3, R4, y R5 están seleccionados independientemente entre el grupo que consiste en hidrógeno, alquenilo, alquilo, haloalquilo, G1, G2, -(CR4aR5a)m-G1, y -(CR4aR5a)m-G2; R4a y R5a, en cada caso, cada uno es independientemente hidrógeno, halógeno, alquilo, o haloalquilo; G1, en cada caso, es independientemente arilo o heteroarilo, donde cada G1 está independientemente sin sustituir osustituido con 1, 2, 3, 4 o 5 sustituyentes seleccionados entre el grupo que consiste en alquilo, alquenilo, alquinilo,halógeno, ciano, -NO2, -OR1b, -OC(O)R1b, -OC(O)N(Rb)(R3b), -SR1b, -S(O)R2b, -S(O)2R2b, -S(O)2N(Rb)(R3b), -C(O)R1b,-C(O)OR1b, -C(O)N(Rb)(R3b), -N(Rb)(R3b), -N(Ra)C(O)R1b, -N(Ra)C(O)O(R1b), -N(Ra)C(O)N(Rb)(R3b), -(CR4bR5b)m-NO2,-N(Rb)S(O)2(R2b), -(CR4bR5b)m-OR1b, -C(OH)[(CR4bR5b)m-R4b]2, -(CR4bR5b)m-OC(O)R1b, -(CR4bR5b)m-OC(O)N(Rb)(R3b), -(CR4bR5b)m-SR1b, -(CR4bR5b)m-S(O)R2b, -(CR4bR5b)m-S(O)2R2b, -(CR4bR5b)m-S(O)2N(Rb)(R3b),-(CR4bR5b)m-C(O)R1b, -(CR4bR5b)m-C(O)OR1b, -(CR4bR5b)m-C(O)N(Rb)(R3b), -(CR4bR5b)m-N(Rb)(R3b), -(CR4bR5b)m-N(Ra)C(O)R1b, -(CR4bR5b)m-N(Ra)C(O)O(R1b), -(CR4bR5b)m-N(Ra)C(O)N(Rb)(R3b), -(CR4bR5b)m-N(Rb)S(O)2(R2b),cianoalquilo, y haloalquilo.
-
公开(公告)号:NZ596827A
公开(公告)日:2014-01-31
申请号:NZ59682710
申请日:2010-05-20
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: WELCH DENNIE S , SHEKHAR SHASHANK , AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , RELO ANA-LUCIA , TURNER SEAN C , GANDARILLA JORGE , WILSON NOEL S , GASIECKI ALAN F , ZHANG MIN , DJURIC STEVAN W , ZHAO HONGYU , KRUGER ALBERT W , THOMPSON CHRISTINA M , LI HUANQIU
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D225/00 , C07D491/04 , C07D495/04
Abstract: 596827 Disclosed is a compound of formula (I), such as (3aS,10bS)-8-chloro-2-methyl-1,2,3,3a,4,5-hexahydrobenzo[e]pyrrolo [3,4-c]azepin-6(10bH)-one and (3aS,10bS)-8-chloro-2-methyl-1,2,3,3a,4,5-hexahydrobenzo[e]pyrrolo [3,4-c]azepin-6(10bH)-one, which is useful for treating disorders associated with 5HT receptors. Also disclosed is a process for making such compounds.
-
公开(公告)号:HK1168853A1
公开(公告)日:2013-01-11
申请号:HK12109595
申请日:2012-09-28
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: WELCH DENNIE S , AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
IPC: C07D20060101 , A61K20060101 , A61P20060101
-
公开(公告)号:MX2011012479A
公开(公告)日:2012-03-06
申请号:MX2011012479
申请日:2010-05-20
Applicant: ABBOTT LAB
Inventor: TURNER SEAN C , GASIECKI ALAN F , AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , ZHANG MIN , DJURIC STEVAN W , GANDARILLA JORGE , SHEKHAR SHASHANK , WILSON NOEL S , RELO ANA-LUCIA , WELCH DENNIE S , KRUGER ALBERT W , ZHAO HONGYU , LI HUANQIU , THOMPSON CHRISTINA M
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D491/04 , C07D495/04
Abstract: La presente solicitud se refiere a derivados de decahidropirroloazepina fusionada a arilo- y heteroarilo, octahidrooxepinopirrol, dióxido de octahidropirrolotiazepina, decahidrociclohepta[c]pirrol, y octahidrociclohepta[cjpirrol de fórmula (I) (ver fórmula (I)) en donde R1, R2, R3, R4, R5, A, Y1, Y2, e Y3 son como se define en la especificación. La presente solicitud también se refiere a composiciones que comprenden tales compuestos, procesos para hacer tales compuestos, y métodos para tratar condiciones de enfermedad utilizando tales compuestos y composiciones y métodos para identificar tales compuestos.
-
公开(公告)号:CA2761961A1
公开(公告)日:2010-11-25
申请号:CA2761961
申请日:2010-05-20
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , WELCH DENNIE S , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D491/04 , C07D495/04
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I), wherein R1,R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
-
公开(公告)号:AU2010353724A1
公开(公告)日:2012-12-20
申请号:AU2010353724
申请日:2010-11-19
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , WELCH DENNIE S , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[
-
公开(公告)号:CA2761961C
公开(公告)日:2017-10-24
申请号:CA2761961
申请日:2010-05-20
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , WELCH DENNIE S , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D491/04 , C07D495/04
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydroox-epinopyrrole, octahydropyrrolothiazepine dioxide, decahy-drocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyr-role derivatives of formula (I), wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
-
公开(公告)号:SG185672A1
公开(公告)日:2013-01-30
申请号:SG2012085346
申请日:2010-11-19
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , WELCH DENNIE S , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
-
公开(公告)号:SG176100A1
公开(公告)日:2011-12-29
申请号:SG2011084357
申请日:2010-05-20
Applicant: ABBOTT LAB
Inventor: AKRITOPOULOU-ZANZE IRINI , BRAJE WILFRIED , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , RELO ANA-LUCIA , SHEKHAR SHASHANK , WELCH DENNIE S , ZHAO HONGYU , GANDARILLA JORGE , GASIECKI ALAN F , LI HUANQIU , THOMPSON CHRISTINA M , ZHANG MIN
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I), wherein R1,R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
-
公开(公告)号:AU2010249472A1
公开(公告)日:2011-12-22
申请号:AU2010249472
申请日:2010-05-20
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: IRINI AKRITOPOULOU-ZANZE , WILFRIED BRAJE , DJURIC STEVAN W , WILSON NOEL S , TURNER SEAN C , KRUGER ALBERT W , ANA-LUCIA RELO , SHASHANK SHEKHAR , WELCH DENNIE S , HONGYU ZHAO , JORGE GANDARILLA , GASIECKI ALAN F , HUANQIU LI , THOMPSON CHRISTINA M , MIN ZHANG
IPC: C07D487/04 , A61K31/551 , A61K31/553 , A61K31/554 , A61P25/00 , C07D491/04 , C07D495/04
Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[]pyrrole, and octahydrocyclohepta[]pyrrole derivatives of formula (I), wherein R,R, R, R, R, A, Y, Y, and Y are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
-
-
-
-
-
-
-
-
-